Keywords: celgene, hit, need, another, thalomid, trial, conduct

Celgene hit by need for another Thalomid trial

Article | 18 March 2002

Print This

Celgene will need to conduct an additional clinical trial of itsThalomid (thalidomide) drug before it can be approved as a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in